CD8A and neoplasm: Although there is a general consensus that Tregs are immunosuppressive and may contribute to treatment failure, the ratio of Tregs and CD8+ effector T cells as well as the timing of changes require further elucidation to comprehensively clarify the relevance of Tregs to the anti-tumor response.